BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 16, 2008
View Archived Issues
New role for endogenous microRNAs in cancer metastasis discovered
Read More
Readthrough AChE splice variant may be linked to Abeta pathology in AD
Read More
Avalon initiates characterization of identified compounds from collaboration with Novartis
Read More
Nventa reports positive data from second cohort of patients in phase I clinical trial of HspE7
Read More
Interim analysis recommends continuation of VITAL-1 trial of GVAX immunotherapy
Read More
Schering-Plough reports results from IDEAL study comparing leading hepatitis C therapies
Read More
Ankrd26 gene disruption gives rise to obesity and gigantism in mice
Read More
FDA sends warning letters over compounded menopause hormone therapy drugs
Read More
Novel antidiabetic agents disclosed in recent Merck Frosst patent
Read More
Recent AstraZeneca and Icos patents describe new agents for respiratory and allergic disorders
Read More
Recent patents disclose new therapeutic agents for obesity and lipoprotein disorders
Read More
Amkor's stroke drug nears end of phase I and prepares for phase II in 2008
Read More
BioCancell receives FDA approval for phase IIb bladder cancer study
Read More
Biofrontera initiates phase III BF-200 ALA trial in actinic keratosis
Read More
Pfizer submits NDA for Fablyn in osteoporosis
Read More
NDA filed for Keppra XR extended-release tablets
Read More
Alvesco gains FDA approval for asthma therapy
Read More
Glenmark's lead diabetes candidate named melogliptin
Read More
Head to head study comparing rosuvastatin and atorvastatin commences
Read More
Pozen submits human lymphocyte study for Treximet to the FDA
Read More
VGX receives FDA clearance to commence clinical trials of VGX-1027
Read More
ZymoGenetics and Merck receive FDA agreement for atacicept SPA in general SLE
Read More
Preliminary results for RVX-208 phase I study show good safety and tolerability
Read More
